TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.280
-0.190 (-7.69%)
Aug 17, 2026, 4:00 PM EDT - Market closed
TuHURA Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 1 | 3.62 | 12.66 | 3.67 | 14.25 |
Cash & Short-Term Investments | 1 | 3.62 | 12.66 | 3.67 | 14.25 |
Cash Growth | -88.30% | -71.40% | 245.35% | -74.28% | - |
Other Receivables | - | 0.67 | 0.64 | 0.33 | - |
Receivables | - | 0.67 | 0.64 | 0.33 | 0.1 |
Other Current Assets | 0.66 | 0.33 | 6.31 | 0.16 | 0.39 |
Total Current Assets | 1.66 | 4.62 | 19.61 | 4.16 | 14.74 |
Property, Plant & Equipment | 0.75 | 0.69 | 0.32 | 0.2 | 0.42 |
Goodwill | 10.74 | 10.74 | - | - | - |
Long-Term Deferred Charges | 11.28 | 11.28 | - | - | - |
Other Long-Term Assets | 7.33 | 0.03 | 0.03 | - | 0.03 |
Total Assets | 31.75 | 27.35 | 19.97 | 4.36 | 15.2 |
Accounts Payable | 3.87 | 3.77 | 3.15 | 1.87 | 1.92 |
Accrued Expenses | - | 1.75 | 2.02 | 1.57 | 0.84 |
Short-Term Debt | 5.17 | 0.2 | - | - | - |
Current Portion of Leases | 0.21 | 0.2 | 0.16 | 0.02 | 0.12 |
Other Current Liabilities | - | - | - | 0.14 | - |
Total Current Liabilities | 9.26 | 5.92 | 5.33 | 3.6 | 2.87 |
Long-Term Debt | 3.6 | - | - | 2.32 | - |
Long-Term Leases | 0.19 | 0.3 | 0.04 | - | 0.02 |
Long-Term Deferred Tax Liabilities | 0.2 | 0.2 | - | - | - |
Total Liabilities | 13.25 | 6.42 | 5.37 | 5.92 | 2.89 |
Common Stock | 0.06 | 0.06 | 0.04 | 0.01 | 0 |
Additional Paid-In Capital | 176.11 | 161.78 | 125.4 | 86.89 | 71.45 |
Retained Earnings | -157.95 | -141.18 | -111.12 | -88.47 | -59.16 |
Total Common Equity | 18.22 | 20.65 | 14.32 | -1.58 | 12.3 |
Shareholders' Equity | 18.5 | 20.93 | 14.59 | -1.56 | 12.3 |
Total Liabilities & Equity | 31.75 | 27.35 | 19.97 | 4.36 | 15.2 |
Total Debt | 9.18 | 0.7 | 0.2 | 2.34 | 0.14 |
Net Cash (Debt) | -8.18 | 2.92 | 12.45 | 1.32 | 14.11 |
Net Cash Growth | - | -76.56% | 843.49% | -90.65% | - |
Net Cash Per Share | -0.14 | 0.06 | 0.67 | 0.11 | - |
Filing Date Shares Outstanding | 63.73 | 63.58 | 43.68 | 68.01 | - |
Total Common Shares Outstanding | 63.68 | 59.34 | 42.32 | 68.01 | - |
Working Capital | -7.6 | -1.3 | 14.28 | 0.56 | 11.87 |
Book Value Per Share | 0.29 | 0.35 | 0.34 | -0.02 | - |
Tangible Book Value | 7.48 | 9.92 | 14.32 | -1.58 | 12.3 |
Tangible Book Value Per Share | 0.12 | 0.17 | 0.34 | -0.02 | - |
Machinery | - | 1.84 | 1.59 | 1.54 | 1.5 |
Leasehold Improvements | - | 0.54 | 0.54 | 0.54 | 0.54 |